Concurrently, the review places a special emphasis on the clinical validation status of the selected combinations, including at the expense of discussing the most prevalent pharmacokinetic problems, formulation issues, and patient safety concerns
S2CID 51652230
REVIEW OF THE LITERATURE Potential therapeutic mechanisms of N-acetylcysteine NAC possesses multiple beneficial pharmacological properties, e.g., anti-inflammatory, antioxidant, minimises cytokine action, modulation release of dopamine, reversing of mitochondrial malfunction, diminishes apoptosis and ferroptosis, improved neurogenesis and boosted glutamate release
While the status of screening for these polymorphisms remains to be established, uncovering the molecular mechanisms responsible for the dysregulation in GSH synthesis may provide novel therapeutic approaches
10.1074/jbc.M209372200 136 YangW
Zhu PJ, Khatiwada S, Cui Ya, Reineke LC, Dooling SW, Kim JJ, Li W, Walter P, Costa-Mattioli M (2019) Activation of the ISR mediates the behavioral and neurophysiological abnormalities in down syndrome
